In vivo imaging of gene and cell therapies.

Molecular imaging can be broadly defined as the in vivo characterization and measurement of biological processes at the cellular and molecular level. In contrast to commonly used clinical imaging, it sets forth to probe the molecular abnormalities that are the basis of disease, rather than imaging the end effects of these molecular alterations. Development of new imaging technologies requires a multidisciplinary collaboration between biologists, chemists, physicists, and imaging scientists to create novel agents, signal amplification strategies, and imaging techniques that successfully address these questions. In this article we attempt to present some of the recent developments and show how molecular imaging can be used, at least experimentally, to assess specific molecular targets for gene- and cell-based therapies. In particular, we place emphasis on the development and use of experimental small-animal models, which are particularly inclined toward this approach, primarily in combination with magnetic resonance (MR), radionuclide, and optical imaging. In the future, specific imaging of disease targets will allow earlier detection and characterization of disease, as well as earlier and direct molecular assessment of treatment efficacy.

[1]  Alan J. Fischman,et al.  Development of a small animal PET imaging device with resolution approaching 1 mm , 1999 .

[2]  H. Benveniste,et al.  Nervous System Defects of AnkyrinB (−/−) Mice Suggest Functional Overlap between the Cell Adhesion Molecule L1 and 440-kD AnkyrinB in Premyelinated Axons , 1998, The Journal of cell biology.

[3]  D Huglo,et al.  Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  A. Ciarmiello,et al.  Scintigraphic detection of multidrug resistance in cancer. , 2000, Cancer biotherapy & radiopharmaceuticals.

[5]  Ronald M Peshock,et al.  Magnetic Resonance Imaging and Invasive Evaluation of Development of Heart Failure in Transgenic Mice With Myocardial Expression of Tumor Necrosis Factor-α , 1999 .

[6]  R E Jacobs,et al.  Fluorescently detectable magnetic resonance imaging agents. , 1998, Bioconjugate chemistry.

[7]  M J Paulus,et al.  High resolution X-ray computed tomography: an emerging tool for small animal cancer research. , 2000, Neoplasia.

[8]  20. The Case for PET/CT. Experience at the University of Pittsburgh. , 2000, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[9]  W. Semmler,et al.  Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands , 2001, Nature Biotechnology.

[10]  B R Masters,et al.  Multiphoton excitation fluorescence microscopy and spectroscopy of in vivo human skin. , 1997, Biophysical journal.

[11]  R E Jacobs,et al.  Magnetic resonance microscopy of embryonic cell lineages and movements. , 1994, Science.

[12]  R K Jain,et al.  Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. , 1999, Cancer research.

[13]  Scott E. Fraser,et al.  In vivo visualization of gene expression using magnetic resonance imaging , 2000, Nature Biotechnology.

[14]  F. Stuart Foster,et al.  High-frequency color flow imaging of the microcirculation , 2000 .

[15]  D. Piwnica-Worms,et al.  Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy. , 2000, Bioconjugate chemistry.

[16]  Simon C Watkins,et al.  Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. , 1998, Circulation.

[17]  R Weissleder,et al.  MR imaging and scintigraphy of gene expression through melanin induction. , 1997, Radiology.

[18]  S. Cherry,et al.  Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R Weissleder,et al.  Paramagnetic metal scavenging by melanin: MR imaging. , 1997, Radiology.

[20]  M E Phelps,et al.  Positron emission tomography provides molecular imaging of biological processes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Donald S. Williams,et al.  Cardiac MRI of the normal and hypertrophied mouse heart , 1998, Magnetic resonance in medicine.

[22]  C. Contag,et al.  Visualizing the kinetics of tumor-cell clearance in living animals. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R K Jain,et al.  Vascular permeability in a human tumour xenograft: molecular charge dependence , 2000, British Journal of Cancer.

[24]  Vicki Brower,et al.  Tumor angiogenesis—new drugs on the block , 1999, Nature Biotechnology.

[25]  C. Contag,et al.  Use of reporter genes for optical measurements of neoplastic disease in vivo. , 2000, Neoplasia.

[26]  R. Webb,et al.  In vivo confocal scanning laser microscopy of human skin: melanin provides strong contrast. , 1995, The Journal of investigative dermatology.

[27]  K. Erlandsson,et al.  Small animal imaging with pinhole single‐photon emission computed tomography , 1994, Cancer.

[28]  R Weissleder,et al.  High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. , 1999, Bioconjugate chemistry.

[29]  M. Rajadhyaksha,et al.  Characterization of psoriasis in vivo by reflectance confocal microscopy. , 1999, Journal of medicine.

[30]  David A. Cheresh,et al.  Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging , 1998, Nature Medicine.

[31]  D. A. Christopher,et al.  40-MHZ echocardiography scanner for cardiovascular assessment of mouse embryos. , 1998, Ultrasound in medicine & biology.

[32]  R Weissleder,et al.  A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. , 1993, Radiology.

[33]  R. Jain,et al.  Imaging of activated natural killer cells in mice by positron emission tomography: preferential uptake in tumors. , 1993, Cancer research.

[34]  J. Ballinger 99mTc‐Tetrofosmin for Functional Imaging of P‐glycoprotein Modulation In Vivo , 2001, Journal of clinical pharmacology.

[35]  N. Umesaki,et al.  Combined diagnostic imaging for retroperitoneal schwannoma. , 2001, Oncology reports.

[36]  S. Larson,et al.  Imaging transgene expression with radionuclide imaging technologies. , 2000, Neoplasia.

[37]  A. Joyner,et al.  Ultrasound backscatter microscope analysis of early mouse embryonic brain development. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Shaun S. Gleason,et al.  A new X-ray computed tomography system for laboratory mouse imaging , 1998 .

[39]  P. So,et al.  Innovations in two-photon deep tissue microscopy , 1999, IEEE Engineering in Medicine and Biology Magazine.

[40]  B Chance,et al.  Near‐Infrared Images Using Continuous, Phase‐Modulated, and Pulsed Light with Quantitation of Blood and Blood Oxygenation a , 1998, Annals of the New York Academy of Sciences.

[41]  M J Paulus,et al.  High resolution computed tomography and MRI for monitoring lung tumor growth in mice undergoing radioimmunotherapy: correlation with histology. , 2000, Medical physics.

[42]  R Weissleder,et al.  Imaging of tumour neovasculature by targeting the TGF-beta binding receptor endoglin. , 2000, European journal of cancer.

[43]  R. Jain,et al.  Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies. , 1998, BioTechniques.

[44]  R. Håkanson,et al.  Methodologic aspects of computed microtomography to monitor the development of osteoporosis in gastrectomized rats. , 1995, Academic radiology.

[45]  D M Shames,et al.  MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation. , 2001, Radiology.

[46]  T. Irimura,et al.  Tumor cells with organ-specific metastatic ability show distinctive trafficking in vivo: analyses by positron emission tomography and bioimaging. , 1997, Cancer research.

[47]  A G Yodh,et al.  Scattering of diffuse photon density waves by spherical inhomogeneities within turbid media: analytic solution and applications. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Y. Yonekura,et al.  Ultra-high resolution SPECT system using four pinhole collimators for small animal studies. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[49]  R. Blasberg,et al.  Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. , 1999, Cancer research.

[50]  Kazuo Hayashi,et al.  High Resolution X-Ray Computed Tomography. , 1993 .

[51]  H. Atkins,et al.  Pinhole SPECT: an approach to in vivo high resolution SPECT imaging in small laboratory animals. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[52]  D. Mankoff,et al.  Positron-emission tomographic imaging of cancer: glucose metabolism and beyond. , 2001, Seminars in radiation oncology.

[53]  H. Tsukada,et al.  Usefulness of positron emission tomographic visualization for examination of in vivo susceptibility to metastasis , 2000, Cancer.

[54]  R. Weissleder,et al.  In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.

[55]  R. Weissleder,et al.  An adduct of cis-diamminedichloroplatinum(II) and poly(ethylene glycol)poly(L-lysine)-succinate: synthesis and cytotoxic properties. , 1996, Bioconjugate chemistry.

[56]  N M Hylton,et al.  Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging. , 1999, Magnetic resonance imaging clinics of North America.

[57]  C. Kao,et al.  Paclitaxel-Based chemotherapy for non-small cell lung cancer: predicting the response with 99mTc-tetrofosmin chest imaging. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[58]  R. Silverman,et al.  High-resolution ultrasonic imaging of blood flow in the anterior segment of the eye. , 1999, Investigative ophthalmology & visual science.

[59]  C. Meares,et al.  Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[60]  R Weissleder,et al.  Near-infrared optical imaging of protease activity for tumor detection. , 1999, Radiology.

[61]  R G Blasberg,et al.  Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. , 1996, Cancer research.

[62]  S. Cherry,et al.  Quantification of target gene expression by imaging reporter gene expression in living animals , 2000, Nature Medicine.

[63]  Ralph Weissleder,et al.  Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.

[64]  Chien Ho,et al.  In Vivo Dynamic MRI Tracking of Rat T‐Cells Labeled with Superparamagnetic Iron‐Oxide Particles , 1995, Magnetic resonance in medicine.

[65]  J. Korlach,et al.  Characterization of lipid bilayer phases by confocal microscopy and fluorescence correlation spectroscopy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[66]  R G Blasberg,et al.  Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Stasia A. Anderson,et al.  Magnetic resonance contrast enhancement of neovasculature with αvβ3‐targeted nanoparticles , 2000 .

[68]  W. Mcbride,et al.  Thrombus imaging using technetium-99m-labeled high-potency GPIIb/IIIa receptor antagonists. Chemistry and initial biological studies. , 1996, Journal of medicinal chemistry.

[69]  Anna Moore,et al.  In vivo magnetic resonance imaging of transgene expression , 2000, Nature Medicine.

[70]  F. Berger,et al.  Breast imaging technology: Recent advances in imaging endogenous or transferred gene expression utilizing radionuclide technologies in living subjects - applications to breast cancer , 2000, Breast Cancer Research.

[71]  M. Abidi,et al.  Reconstruction of multi-energy X-ray computed tomography images of laboratory mice , 1999 .

[72]  S. Cherry,et al.  Performance evaluation of microPET: a high-resolution lutetium oxyorthosilicate PET scanner for animal imaging. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[73]  A Haase,et al.  Developmental changes of cardiac function and mass assessed with MRI in neonatal, juvenile, and adult mice. , 2000, American journal of physiology. Heart and circulatory physiology.

[74]  M E Easterly,et al.  A review of high-resolution X-ray computed tomography and other imaging modalities for small animal research. , 2001, Lab animal.

[75]  S. Cherry,et al.  PET imaging of transgene expression , 2000, Biological Psychiatry.

[76]  Chien Ho,et al.  Intracellular labeling of T‐cells with superparamagnetic contrast agents , 1993, Magnetic resonance in medicine.

[77]  Daniel H. Turnbull,et al.  A method for rapid gain-of-function studies in the mouse embryonic nervoussystem , 1999, Nature Neuroscience.

[78]  V. Ntziachristos,et al.  Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[79]  J. Ballinger Imaging multidrug resistance with radiolabeled substrates for P-glycoprotein and multidrug resistance protein. , 2001, Cancer biotherapy & radiopharmaceuticals.

[80]  G A Johnson,et al.  Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[81]  R Weissleder,et al.  Measuring transferrin receptor gene expression by NMR imaging. , 1998, Biochimica et biophysica acta.

[82]  Stefan Neubauer,et al.  Magnetic resonance microimaging for noninvasive quantification of myocardial function and mass in the mouse , 1998, Magnetic resonance in medicine.

[83]  H. Bergh,et al.  Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice. , 1994, Cancer research.

[84]  C. Pozzilli,et al.  TRACKING OF INDIUM‐111‐OXINE LABELLED LYMPHOCYTES IN AUTOIMMUNE THYROID DISEASE , 1983, Clinical endocrinology.

[85]  Krzysztof P Bobinski,et al.  Seeing is believing: Non‐invasive, quantitative and repetitive imaging of reporter gene expression in living animals, using positron emission tomography , 2000, Journal of neuroscience research.

[86]  G. Johnson,et al.  Magnetic Resonance Microscopy of the C57BL Mouse Brain , 2000, NeuroImage.

[87]  James F. Young,et al.  MicroPET: a high resolution PET scanner for imaging small animals , 1996, IEEE Nuclear Science Symposium Conference Record.

[88]  S S Gambhir,et al.  Use of positron emission tomography in animal research. , 2001, ILAR journal.

[89]  J. Marota,et al.  Design and evaluation of a continuous-wave diffuse optical tomography system. , 1999, Optics Express.

[90]  L E Williams,et al.  Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts. , 1996, Cancer research.

[91]  T Ragan,et al.  New time-resolved techniques in two-photon microscopy. , 1998, Cellular and molecular biology.

[92]  T. Irimura,et al.  Real-time PET analysis of metastatic tumor cell trafficking in vivo and its relation to adhesion properties. , 1995, Biochimica et biophysica acta.

[93]  R. Weissleder,et al.  Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brain. , 1995, The American journal of pathology.

[94]  M. Tatematsu,et al.  Real‐time observation of micrometastasis formation in the living mouse liver using a green fluorescent protein gene–tagged rat tongue carcinoma cell line , 2001, International journal of cancer.

[95]  S. Goldman,et al.  Combined magnetic resonance imaging- and positron emission tomography-guided stereotactic biopsy in brainstem mass lesions: diagnostic yield in a series of 30 patients. , 2000, Journal of neurosurgery.

[96]  Scott E. Fraser,et al.  A SMART MAGNETIC RESONANCE IMAGING AGENT THAT REPORTS ON SPECIFIC ENZYMATIC ACTIVITY , 1997 .

[97]  Dario Neri,et al.  Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform , 1997, Nature Biotechnology.

[98]  T Irimura,et al.  Positron emission tomography analysis of metastatic tumor cell trafficking. , 1994, Cancer research.